Patrick T

Recent Articles

Analyst Says CA Pharma Underappreciated by Investors 07/23/2024

Arrowhead Pharmaceuticals Inc. (ARWR:NASDAQ) recently hosted a webinar going over its pulmonary programs. Read on to see why an H.C. Wainwright & Co. analyst believes the company is underappreciated by investors.